Mara Files Inter Partes Review (IPR) Petition in the U.S. Challenging Validity of DSM Patent No. 10,392,578: Extraction of Lipid from Cells and Products Therefrom

Mara Renewables Corporation, and its manufacturing partner Algal Omega-3 (AO3), announced today they have filed an IPR in the United States on DSM Patent No. 10,392,578, titled Extraction of Lipid from Cells and Products Therefrom, asserting that the patent is not valid, based upon its obviousness. According to the filing, prior art discloses each of the elements of the challenged claims.

“Mara does not believe that all DSM patents meet the high standard required by the patent office. Through the actions brought on by DSM, we have reviewed the strength of DSM's IP and recognized that there are several patents that, in our view, should not have been granted. It is our intent to challenge those patents that we believe don't meet the required standards. We look forward to the review of our petition on this patent,” said Mark Scaife, Managing Director.

About Mara

Based in Halifax, Canada, Mara Renewables is a world-class manufacturer and leading global supplier of its patented algal-derived omega-3 oil DHA. It meets the growing needs of plant-based and environmentally conscious brands and consumers, providing functional, innovative ingredients that improve human nutrition without depleting our planet’s most valuable natural resources. In 2021 alone, Mara supplied DHA-rich fatty acids to the nutritional supplement, and food and beverage markets to offset an estimated 7.3 billion fish (anchovy).

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230718372073/en/

Contact information

Margie Adelman
Adelman PR & Consulting Inc.
madelmanpr@gmail.com
M: 916- 220 3500